During the past five years, investing in cannabis stocks has led to dreadful returns for investors. One of the top cannabis ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.iXkfgCgn.js ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 5 includes Boeing, Warby Parker, SentinelOne, ...

Thank you for joining us for today's conference call to discuss Tilray Brands' financial results for the second quarter ended ...

Q2 2025 Earnings Call Transcript January 9, 2025 Operator: Thank you for joining us for today’s conference call to discuss ...

Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its ...

However, we see little synergies across Tilray's portfolio of cannabis, alcoholic beverages, and wellness products as the markets, distribution systems, and regulatory systems are vastly different.

Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments. Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net ...

Analyst Robert Moskow of TD Cowen maintained a Buy rating on Tilray (TLRY – Research Report), with a price target of $1.50.Stay Ahead of the ...

New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.

Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented ...